BRPI1013762A2 - "derivados isoxazol-piridazina" - Google Patents
"derivados isoxazol-piridazina"Info
- Publication number
- BRPI1013762A2 BRPI1013762A2 BRPI1013762-9A BRPI1013762A BRPI1013762A2 BR PI1013762 A2 BRPI1013762 A2 BR PI1013762A2 BR PI1013762 A BRPI1013762 A BR PI1013762A BR PI1013762 A2 BRPI1013762 A2 BR PI1013762A2
- Authority
- BR
- Brazil
- Prior art keywords
- isoxazole
- pyridazine derivatives
- pyridazine
- derivatives
- isoxazole pyridazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09159412 | 2009-05-05 | ||
| PCT/EP2010/055669 WO2010127968A1 (en) | 2009-05-05 | 2010-04-28 | Isoxazole-pyridazine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1013762A2 true BRPI1013762A2 (pt) | 2015-08-25 |
Family
ID=42331035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1013762-9A BRPI1013762A2 (pt) | 2009-05-05 | 2010-04-28 | "derivados isoxazol-piridazina" |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8410104B2 (pt) |
| EP (1) | EP2427458B1 (pt) |
| JP (1) | JP6026273B2 (pt) |
| KR (1) | KR101701533B1 (pt) |
| CN (1) | CN102414204B (pt) |
| AU (1) | AU2010244545A1 (pt) |
| BR (1) | BRPI1013762A2 (pt) |
| CA (1) | CA2760597C (pt) |
| ES (1) | ES2467701T3 (pt) |
| IL (1) | IL215109A0 (pt) |
| MX (1) | MX2011011477A (pt) |
| SG (1) | SG175780A1 (pt) |
| WO (1) | WO2010127968A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0914305B8 (pt) * | 2008-06-19 | 2021-05-25 | Xcovery Holding Co Llc | compostos de piridazina carboxamida substituída como compostos inibidores da quinase, uso dos compostos e uso de uma composição compreendendo os compostos |
| US20100280019A1 (en) * | 2009-04-30 | 2010-11-04 | Roland Jakob-Roetne | Isoxazoles |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| WO2014001280A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| KR20150033679A (ko) | 2012-06-26 | 2015-04-01 | 사니오나 에이피에스 | 페닐 트리아졸 유도체 및 이의 gabaa 수용체 복합체 조절용 용도 |
| MX357504B (es) | 2012-06-26 | 2018-07-12 | Saniona Aps | Derivado de feniltriazol y su uso para modular complejo del receptor gabaa. |
| WO2014001278A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| WO2014001279A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| MX2016015873A (es) * | 2014-06-03 | 2017-03-27 | Hoffmann La Roche | Peptidos como agonistas de oxitocina. |
| CR20160562A (es) * | 2014-06-06 | 2017-01-06 | Hoffmann La Roche | Péptidos como agonistas de la oxitocina |
| BR102019014802A2 (pt) | 2018-07-20 | 2020-02-04 | Boehringer Ingelheim Int | difluorometil-fenil triazóis |
| CN115515581A (zh) | 2020-01-10 | 2022-12-23 | 帕西拉制药股份有限公司 | 通过给予缓释脂质体麻醉组合物治疗疼痛 |
| EP4087554A4 (en) | 2020-01-10 | 2024-01-17 | Pacira Pharmaceuticals Inc | TREATMENT OF PAIN BY SUBARACHNOID ADMINISTRATION OF SUSTAINED-RELEASE LIPOSOMAL ANESTHETICAL COMPOSITIONS |
| WO2022150708A1 (en) | 2021-01-11 | 2022-07-14 | Pacira Pharmaceuticals, Inc. | Treatment of hip pain with sustained-release liposomal anesthetic compositions |
| EP4308084A2 (en) | 2021-03-19 | 2024-01-24 | Pacira Pharmaceuticals, Inc. | Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions |
| US11918565B1 (en) | 2022-11-03 | 2024-03-05 | Pacira Pharmaceuticals, Inc. | Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3525205A1 (de) | 1984-09-11 | 1986-03-20 | Hoechst Ag, 6230 Frankfurt | Pflanzenschuetzende mittel auf basis von 1,2,4-triazolderivaten sowie neue derivate des 1,2,4-triazols |
| GB9808663D0 (en) | 1998-04-23 | 1998-06-24 | Merck Sharp & Dohme | Therapeutic agents |
| US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| IT1314191B1 (it) | 1999-10-18 | 2002-12-06 | Recordati Chem Pharm | Derivati isossazolcarbossamidici |
| JP2003513975A (ja) | 1999-11-12 | 2003-04-15 | ニューロゲン コーポレイション | 二環式および三環式のヘテロ芳香族化合物 |
| PA8535601A1 (es) | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
| GB0108475D0 (en) | 2001-04-04 | 2001-05-23 | Merck Sharp & Dohme | New compounds |
| MXPA03011886A (es) | 2001-07-05 | 2005-03-07 | Lundbeck & Co As H | Piperidinias anilinicas sustituidas como antagonistas selectivos de mch. |
| ATE381542T1 (de) | 2001-08-13 | 2008-01-15 | Phenex Pharmaceuticals Ag | Nr1h4-kern-rezeptor-bindende verbindungen |
| ES2299618T3 (es) | 2001-11-20 | 2008-06-01 | Eli Lilly And Company | Agonistas beta-3-adrenergicos. |
| GB0128160D0 (en) | 2001-11-23 | 2002-01-16 | Merck Sharp & Dohme | Novel compounds |
| AU2003290700A1 (en) | 2002-11-22 | 2004-06-18 | Smithkline Beecham Corporation | Farnesoid x receptor agonists |
| GB0318447D0 (en) | 2003-08-05 | 2003-09-10 | Merck Sharp & Dohme | Therapeutic agents |
| EP1756086B1 (en) | 2004-06-01 | 2008-06-04 | F.Hoffmann-La Roche Ag | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists |
| EP1773807A2 (en) | 2004-06-14 | 2007-04-18 | Takeda San Diego, Inc. | Kinase inhibitors |
| GB0418267D0 (en) * | 2004-08-16 | 2004-09-15 | Glaxo Group Ltd | Novel compounds |
| JP4620123B2 (ja) | 2004-10-01 | 2011-01-26 | エフ．ホフマン−ラ ロシュ アーゲー | ヘキサフルオロイソプロパノール置換エーテル誘導体 |
| US7351724B2 (en) | 2004-10-15 | 2008-04-01 | The Scripps Research Institute | Oxadiazole ketone inhibitors of fatty acid amide hydrolase |
| US20070060589A1 (en) | 2004-12-21 | 2007-03-15 | Purandare Ashok V | Inhibitors of protein arginine methyl transferases |
| ES2314943T3 (es) | 2005-09-19 | 2009-03-16 | F. Hoffmann-La Roche Ag | Derivados de isoxazolo como agonistas inversos de gaba a alfa. |
| ATE526318T1 (de) | 2005-12-19 | 2011-10-15 | Glaxosmithkline Llc | Farnesoid-x-rezeptor-agonisten |
| EP1984360B1 (en) | 2006-02-03 | 2014-01-15 | Eli Lilly & Company | Compounds and methods for modulating FX-receptors |
| EP1894924A1 (en) | 2006-08-29 | 2008-03-05 | Phenex Pharmaceuticals AG | Heterocyclic FXR binding compounds |
| EP1894928A1 (en) | 2006-08-29 | 2008-03-05 | PheneX Pharmaceuticals AG | Heterocyclic fxr binding compounds |
| US7943619B2 (en) | 2007-12-04 | 2011-05-17 | Hoffmann-La Roche Inc. | Isoxazolo-pyridazine derivatives |
| US20100280019A1 (en) * | 2009-04-30 | 2010-11-04 | Roland Jakob-Roetne | Isoxazoles |
-
2010
- 2010-04-28 CA CA2760597A patent/CA2760597C/en not_active Expired - Fee Related
- 2010-04-28 JP JP2012508986A patent/JP6026273B2/ja active Active
- 2010-04-28 BR BRPI1013762-9A patent/BRPI1013762A2/pt not_active Application Discontinuation
- 2010-04-28 MX MX2011011477A patent/MX2011011477A/es active IP Right Grant
- 2010-04-28 EP EP10719306.2A patent/EP2427458B1/en not_active Not-in-force
- 2010-04-28 AU AU2010244545A patent/AU2010244545A1/en not_active Abandoned
- 2010-04-28 ES ES10719306.2T patent/ES2467701T3/es active Active
- 2010-04-28 CN CN201080019263.7A patent/CN102414204B/zh active Active
- 2010-04-28 SG SG2011077898A patent/SG175780A1/en unknown
- 2010-04-28 KR KR1020117026119A patent/KR101701533B1/ko active IP Right Grant
- 2010-04-28 WO PCT/EP2010/055669 patent/WO2010127968A1/en active Application Filing
- 2010-04-28 US US12/768,765 patent/US8410104B2/en active Active
-
2011
- 2011-09-12 IL IL215109A patent/IL215109A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG175780A1 (en) | 2011-12-29 |
| AU2010244545A1 (en) | 2011-10-13 |
| EP2427458A1 (en) | 2012-03-14 |
| CA2760597A1 (en) | 2010-11-11 |
| JP2012526068A (ja) | 2012-10-25 |
| CA2760597C (en) | 2017-08-22 |
| MX2011011477A (es) | 2011-11-18 |
| US8410104B2 (en) | 2013-04-02 |
| JP6026273B2 (ja) | 2016-11-16 |
| IL215109A0 (en) | 2011-12-29 |
| EP2427458B1 (en) | 2014-05-07 |
| WO2010127968A1 (en) | 2010-11-11 |
| KR101701533B1 (ko) | 2017-02-13 |
| US20100286159A1 (en) | 2010-11-11 |
| CN102414204B (zh) | 2014-12-31 |
| KR20120027204A (ko) | 2012-03-21 |
| ES2467701T3 (es) | 2014-06-12 |
| CN102414204A (zh) | 2012-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1013762A2 (pt) | "derivados isoxazol-piridazina" | |
| BRPI1011813A2 (pt) | "inalador" | |
| BR112012012872A2 (pt) | "pirrolindinas de espiroindolinona" | |
| BRPI1010909A2 (pt) | "inseticida arilpirrolinas" | |
| BRPI1009315A2 (pt) | agentes anti-inflamatórios | |
| FR2941508B1 (fr) | Agencement d'entrainement | |
| BRPI1012004A2 (pt) | "forma farmacêutica" | |
| BR112012010595A2 (pt) | "dispensdor" | |
| BRPI1013030A2 (pt) | "aquecedores" | |
| BR112012004593A2 (pt) | "método" | |
| ECSP12011999A (es) | Derivados benzamida sustituidos | |
| BR112012004444A2 (pt) | "laringoscópio" | |
| DK2397480T3 (da) | Diazepindionderivat | |
| FR2950411B1 (fr) | Agencement d'entrainement | |
| IT1395915B1 (it) | Potabilizzatore d'acqua | |
| DK2387580T3 (da) | Deoxyactagardinderivater | |
| FR2944062B1 (fr) | Injecteur d'ergols | |
| BRPI1008173A2 (pt) | "derivados de piridina espiroindolinona" | |
| BRPI1011416A2 (pt) | derivados de antraquinova novos | |
| BRPI1010178A2 (pt) | "válvula" | |
| SMT201600041B (it) | Agenti terapeutici 713 | |
| BRPI1009059A2 (pt) | "peça de vestuário" | |
| BRPI1006474A2 (pt) | "gatilho" | |
| MA30860B1 (fr) | Myrtillier denomme "c97-390" | |
| IT1399458B1 (it) | "mandrino" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |